The Effect of Time to Castration Resistance on Overall Survival and Success of Docetaxel Treatment in Castration Resistant Prostate Cancer Patients.

SÜER, EVREN; Hamidi, Nurullah; Akpinar, ÇAĞRI; GÖKCE, MEHMET; GÜLPINAR, ÖMER; Turkolmez, KADİR; Beduk, Yasar; BALTACI, SÜMER

doi:10.22037/uj.v0i0.4497

The Effect of Time to Castration Resistance on Overall Survival and Success of Docetaxel Treatment in Castration Resistant Prostate Cancer Patients.

SÜER E., Hamidi N., Akpinar Ç., GÖKCE M. İ., GÜLPINAR Ö., Turkolmez K., ...Daha Fazla

Urology journal, cilt.16, sa.5, ss.453-457, 2019 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 16 Sayı: 5
Basım Tarihi: 2019
Doi Numarası: 10.22037/uj.v0i0.4497
Dergi Adı: Urology journal
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.453-457
Anahtar Kelimeler: castration, chemotherapy, docetaxel, prostate cancer, survival, ABIRATERONE ACETATE, DOUBLE-BLIND, MITOXANTRONE, CABAZITAXEL, PREDNISONE, THERAPY, MEN
Ankara Üniversitesi Adresli: Evet

Özet

Purpose: To investigate the prognostic role of time to castration resistance(TTCR) in patients who have received solely Docetaxel chemotherapy regimen(DCR) for castration resistant prostate cancer(CRPC).